Methyl-cyclopentadienyl Ruthenium Compounds with 2,2'-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential.
Côrte-Real L, Teixeira RG, Gírio P, Comsa E, Moreno A, Nasr R, Baubichon-Cortay H, Avecilla F, Marques F, Robalo MP, Mendes P, Ramalho JPP, Garcia MH, Falson P, Valente A.
Côrte-Real L, et al. Among authors: garcia mh.
Inorg Chem. 2018 Apr 16;57(8):4629-4639. doi: 10.1021/acs.inorgchem.8b00358. Epub 2018 Apr 3.
Inorg Chem. 2018.
PMID: 29611696